HuGE Literature Finder
Records
1
-
4
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response. Pharmacogenomics 2015 Dec . Huang Eric, Maciukiewicz Malgorzata, Zai Clement C, Tiwari Arun K, Li Jiang, Potkin Steven G, Lieberman Jeffrey A, Meltzer Herbert Y, Müller Daniel J, Kennedy James |
Comparing the influence of dopamine D2 polymorphisms and plasma drug concentrations on the clinical response to risperidone. Journal of clinical psychopharmacology 2011 Oct 31 (5): 633-7. Yasui-Furukori Norio, Tsuchimine Shoko, Saito Manabu, Nakagami Taku, Sugawara Norio, Fujii Akira, Kaneko Sun |
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. The American journal of psychiatry 2010 Jul 167 (7): 763-72. Zhang Jian-Ping, Lencz Todd, Malhotra Anil |
The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007 Oct 10 (5): 631-7. Xing Qinghe, Qian Xueqing, Li Huafang, Wong Shiming, Wu Shengnan, Feng Guoyin, Duan Shiwei, Xu Mingqing, Gao Rui, Qin Wei, Gao Jianjun, Meng Junwei, He L |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: